Q2 2025

Filed Aug 11, 2025 · 10-Q · 42 days after period end · 0000950170-25-106549

Q2 2025 · 10-Q

Revenue

$1.35M

+35.1% vs Q2 2024

Net Income

-$7.60M

N/M vs Q2 2024

EPS Diluted

-$1.88

N/M vs Q2 2024

Operating Income-$12,052,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	$1.35M	$998.00K	$44.32M	$29.81M
Net Income	-$7.60M	-$15.54M	-$87.68M	-$72.62M
EPS Diluted	-$1.88	-$3.89	-$0.90	-$0.78

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR